ROYAL BANK OF CANADA - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$29,000
+123.1%
9,999
+122.9%
0.00%
Q2 2023$13,000
+8.3%
4,485
+10.5%
0.00%
Q1 2023$12,000
-33.3%
4,057
-54.0%
0.00%
Q4 2022$18,000
+1700.0%
8,816
+3818.2%
0.00%
Q3 2022$1,000225
+127.3%
0.00%
Q2 2022$0
-100.0%
99
-96.0%
0.00%
Q1 2022$17,0002,447
+4431.5%
0.00%
Q4 2021$0540.00%
Other shareholders
HUMACYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders